Bluerock RE Fund trustee granted 1,012 shares

Bluerock Private Real Estate Fund (BPRE) reported that trustee Bobby I. Majumder acquired Common Shares of Beneficial Interest through non-market transactions under the trustees' compensation plan.

Rhea-AI Filing Summary

Bluerock Private Real Estate Fund (BPRE) reported that trustee Bobby I. Majumder acquired Common Shares of Beneficial Interest through non-market transactions under the trustees' compensation plan. The grants were 333.33 shares at $15.00 on December 31, 2025; 301.02 shares at $16.61 on March 31, 2026; and 378.12 shares at $13.22 on June 30, 2026.

Insider Trade Summary

Other: 1,012.47 shares

Other 3 txns

Insider Majumder I. Bobby

Role Insider

Type	Security	Shares	Price	Value
Other	Common Shares of Beneficial Interest F1	378.12	$13.22	$5K
Other	Common Shares of Beneficial Interest F1	301.02	$16.61	$5K
Other	Common Shares of Beneficial Interest F1	333.33	$15.00	$5K

Holdings After Transaction: Common Shares of Beneficial Interest — 4,563.56 shares (Direct)

Footnotes (1)

1. F1. Consists of shares granted in conjunction with the trustees' compensation plan.

Key Figures

Shares acquired 2025-12-31: 333.33 Common Shares of Beneficial Interest at $15.00 per share Shares acquired 2026-03-31: 301.02 Common Shares of Beneficial Interest at $16.61 per share Shares acquired 2026-06-30: 378.12 Common Shares of Beneficial Interest at $13.22 per share +1 more

4 metrics

Shares acquired 2025-12-31 333.33 Common Shares of Beneficial Interest at $15.00 per share Other acquisition (code J) under trustees' compensation plan

Shares acquired 2026-03-31 301.02 Common Shares of Beneficial Interest at $16.61 per share Other acquisition (code J) under trustees' compensation plan

Shares acquired 2026-06-30 378.12 Common Shares of Beneficial Interest at $13.22 per share Other acquisition (code J) under trustees' compensation plan

Total restructuring-related shares 1,012.47 shares Total shares in restructuring/other acquisition transactions reported

Key Terms

Common Shares of Beneficial Interest, trustees' compensation plan, Section 16(a) Filings, Rule 10b5-1

4 terms

Common Shares of Beneficial Interest financial

"security_title: "Common Shares of Beneficial Interest""

Common Shares of Beneficial Interest are units that represent ownership in a company or organization, like owning a piece of a pie. They give investors voting rights and a chance to share in profits, making them important for those looking to invest and have a say in how the organization is run.

trustees' compensation plan financial

"Consists of shares granted in conjunction with the trustees' compensation plan."

Section 16(a) Filings regulatory

"Limited Power of Attorney for Section 16(a) Filings, dated 7-18-22"

Rule 10b5-1 regulatory

"Rule 10b5-1 checkbox is not checked for these transactions"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transactions did BPRE trustee Bobby I. Majumder report?

He reported three acquisitions of Common Shares of Beneficial Interest, totaling 1,012.47 shares, received on December 31, 2025; March 31, 2026; and June 30, 2026, in conjunction with the trustees' compensation plan.

Were the BPRE Form 4 transactions open-market purchases or compensation grants?

The footnote states the reported 1,012.47 shares “consist of shares granted in conjunction with the trustees' compensation plan,” indicating they are compensation-related grants rather than open-market purchases or sales.

On what dates were the BPRE trustee compensation shares granted?

Bobby I. Majumder received share grants on December 31, 2025, March 31, 2026, and June 30, 2026, all recorded as other acquisitions (code J) of Common Shares of Beneficial Interest.

What were the per-share values used for the BPRE trustee share grants?

The grants were valued at $15.00 per share on December 31, 2025; $16.61 per share on March 31, 2026; and $13.22 per share on June 30, 2026, for Common Shares of Beneficial Interest.

Are the BPRE trustee transactions reported under a Rule 10b5-1 trading plan?

The Rule 10b5-1 checkbox is not checked, and there is no footnote indicating a trading plan, so these compensation-related grants are not affirmatively reported as made under a Rule 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/27/2026 - 06:33 PM Accepted by SEC EDGAR 08/27/2026 - 06:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Majumder I. Bobby

(Last) (First) (Middle)

919 THIRD AVENUE

40TH FLOOR

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bluerock Private Real Estate Fund [ BPRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Trustee

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares of Beneficial Interest	12/31/2025		J(1)		333.33	A	$15	3,821.88	D
Common Shares of Beneficial Interest	03/31/2026		J(1)		301.02	A	$16.61	4,122.9	D
Common Shares of Beneficial Interest	06/30/2026		J(1)		378.12	A	$13.22	4,563.56	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of shares granted in conjunction with the trustees' compensation plan.

Remarks:

***Attorney-In-Fact, Pursuant to Limited Power of Attorney for Section 16(a) Filings, dated 7-18-22

	/s/ JoAnn M. Strasser***	08/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)